Delivery Order SPE2DB20D3101-SPE2DB23FQVP9

Award Date 11/25/22
Potential Completion Date 11/28/22
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,604.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Oseltamivir 6 mg/ml suspension, a critical antiviral medication, for a period ending on December 23, 2024. The contract has a firm fixed-price pricing structure and was not designated as a set-aside. AmerisourceBergen holds a substantial Indefinite...
This federal contract award, with an ID of SPE2DX15D1022|SPE2DX25FVDFQ, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,542.75 firm fixed-price delivery order is for the supply of 60ml bottles of the medication Oseltamivir 6 mg/ml suspension. The contract has an ultimate completion date of March 18, 2025 and was awarded on March 17, 2025. Amerisourcebergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,904.16 and is for the delivery of Oseltamivir 6 mg/mL suspension, a 60 mL anti-viral medication. The contract is a firm fixed-price delivery order with a period of performance through March 17, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award, with a contract ID of SPE2DB22D2007|SPE2DB25FJ0AM, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Oseltamivir 6 mg/ml suspension in 60 ml quantities, with a ceiling value of $3,087.95 and a completion date of March 21, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,429.42 firm fixed-price delivery order contract is for the supply of 4566989335 - OSELTAMIVIR 6 MG/ML SUSPENSION 60ML. The contract has an ultimate completion date of January 22, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, including the DLA....
This federal contract award, valued at $1,021.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Oseltamivir 6 mg/ml suspension (60 ml) and has a completion date of November 22, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization that serves as a critical supplier of pharmaceutical products and medical supplies to...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,687.35, is for the delivery of 60 ml of Oseltamivir 6 mg/ml suspension. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,996.69 fixed-price delivery order is for the procurement of 60ml bottles of the drug Oseltamivir 6 mg/ml suspension, with a completion date of December 22, 2021. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, SPE2DB22D1106|SPE2DB24FDRT3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,129.40 firm fixed-price delivery order is for the supply of 4,563,157,638 units of Oseltamivir Phosphate 75 mg capsules, a medication used to treat influenza. The contract has an ultimate completion date of December 21, 2023 and was awarded on December 20, 2022. Amerisourcebergen...
This federal contract award, SPE2DB22D3016|SPE2DB24FANW7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,334.64 firm fixed-price delivery order is for the supply of 60ml bottles of a 6mg/ml suspension of the antiviral drug Oseltamivir, with a completion date of March 4, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen also holds...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FQVP9
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp is a delivery order (SPE2DB23FQVP9) under the Defense Logistics Agency's (DLA) Indefinite Delivery Contract (IDC) SPE2DB20D3101, valued at $2,444.45 for the purchase of Oseltamivir 6 mg/ml suspension (60 ml). The contract was awarded on November 25, 2022, with an ultimate completion date of November 28, 2022. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider, registered in the System for Award Management (SAM.gov) as a for-profit organization. This contract supports the DLA Troop Support Medical, which provides pharmaceutical and medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:22 AM